Biotechnology News

August 22, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen’s rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured...

August 21, 2012

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the quarter ended June 30, 2012. Sales were $96.0 million, an 18.6% increase from the second quarter...

August 21, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Jack Talley has resigned as President and CEO of the Company and as a member of the Board of Directors...

August 21, 2012

ZUG, Switzerland--(BUSINESS WIRE)--PSI-CRO heartily congratulates the Alchemia team on their success in the “Ride to Conquer Cancer’ which took place in Brisbane, Australia over the weekend of August 18-19. PSI is currently providing clinical...

August 21, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that CEO Frank Reynolds...

August 21, 2012

SEATTLE--(BUSINESS WIRE)--RareCyte Inc., a Seattle-based life science company, closed the second tranche of its funding led by Telegraph Hill Partners (THP). Founded in 2009, RareCyte is focused on the development of the AccuCyteTM System, a rare...

August 21, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Truven Health Analytics defines best practices for unlocking the analytical value of ICD-10 disease classification system

August 21, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ: FLDM) announced that it has closed the previously announced underwritten public offering of 4,209,000 shares of its common stock at a price to the public of $14.25 per share.

August 21, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Inc. Magazine Names Clinipace Worldwide to its 2012 Inc. 500 List for Third Consecutive Year. Clinipace ranked 260th, moving up 19 spots from 2011.

August 21, 2012

LOS ANGELES--(BUSINESS WIRE)--Fidelis Diagnostics Enters Workers Compensation Market with “Gold Standard” Diagnostic Testing Solutions

August 21, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that coverage of injectable type 2 diabetes therapies by public programs for...

August 21, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that in the United States and Europe there is strong physician desire for new therapies...

August 21, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration...

August 21, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--iRounds, a physician-owned provider of mobile and web platforms for patient care communication in a secure and HIPAA compliant format, selected Online Tech as their trusted hosting business associate. Online...

August 21, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application (NDA) for tofacitinib, an investigational oral treatment...

August 21, 2012

MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing...

August 21, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera adds VP, Finance

August 21, 2012

SÃO PAULO--(BUSINESS WIRE)--Systagenix, a global leader in wound management, launches two new advanced wound care products in Brazil - SILVERCEL® NON-ADHERENT and ADAPTIC® DIGIT.

August 21, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--New ways to improve stroke diagnostics are needed. Gordon Conference poster shows benefits of using Oxygen Bio's Oxycyte in conjunction with MRI to identify penumbra.

August 21, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products, announced today the appointment of ...

August 21, 2012

SEATTLE--(BUSINESS WIRE)--Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits...

August 21, 2012

IRVINE, Calif. & ZURICH-SCHLIEREN, Switzerland--(BUSINESS WIRE)--Allergan and Molecular Partners announce they have expanded their relationship by entering into two separate agreements in R&D and to commercialize DARPin® products...

August 21, 2012

MILWAUKEE & HERZLIYA & LOD, Israel--(BUSINESS WIRE)--GE (NYSE: GE), together with OrbiMed Israel and Ornim, Inc., announced today a $20 million investment in Ornim, Inc., a developer of the CerOx™ monitor that non-invasively monitors...

August 21, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac today announced that it is launching a Next Generation Sequencing service to further expand its range of solutions supporting the development of personalised medicine. The purpose of this...

August 21, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced the renegotiation of its 2010 strategic partnership agreement with Inspiration Biopharmaceuticals, Inc. (Inspiration) for the development and...

August 21, 2012

HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix announces it will begin commercialization of its BNP (BioNanoPore) and BNF (BioNanoFilter) diagnostic kits under FDA 510K-exempt status.

August 21, 2012

HYDERABAD, India--(BUSINESS WIRE)--Inogent Laboratories clears the Pharmaceuticals and Medical Devices Agency (PMDA), Japan Audit

August 20, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that it has priced its offering of $1 billion in senior notes. The offering consists of two tranches: $500 million aggregate...

August 20, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the closing of the sale of 2,359,932 shares of its common stock and warrants to purchase up to 1,179,966 additional shares of its common stock in a...

August 20, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics is pleased to announce that the swimmable Neptune™ processor has earned a prestigious product design award from the German-based Red Dot Institute for Advanced Design Studies.

August 20, 2012

RICHMOND, Va.--(BUSINESS WIRE)--The recently enacted Synthetic Drug Abuse Prevention Act of 2012 placed “cannabimimetic agents” and certain classes of amphetamine-like stimulants into the Controlled Substance Act. These compounds were placed into...

August 20, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Southern Research's Developmental and Reproductive Toxicology program (DART) offers clients specialized assessments to determine drug and chemical affects on reproductive systems.

August 20, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in both basic...

August 20, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches with...

August 20, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Life sciences companies are finding value in compliance solutions that help them go to market faster, and this award demonstrates our ability to optimize and accelerate their processes

August 20, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that Scotland’s NHS Lothian has been confirmed as a site for its Phase I/II human clinical...

August 20, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer releases newest version of flagship informatics product: ChemBioOffice® Ultra 13.0 suite to accelerate the discovery process through increased productivity and data sharing

August 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the initiation of a multi-center Phase 1/2 clinical trial in Japan of ponatinib, the Company’s investigational BCR-ABL inhibitor. The trial is being...

August 20, 2012

PLEASANTON, Calif. & THE HAGUE, Netherlands--(BUSINESS WIRE)--IntegenX today launched its RapidHIT™ Human DNA Identification System to the European law enforcement and forensic communities at the 6th European Academy of Forensic Science (EAFS...

August 20, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--ELIQUIS® (apixaban) Data Analyses To Be Presented At European Society of Cardiology Congress 2012

August 20, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced the appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., to the new position of Executive Vice President, Chief Operating Officer, and the appointment of Burt Adelman...

August 18, 2012

MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--PhotoMedex, Inc. (NASDAQ and TASE: PHMD) today announced that the Board of Directors has authorized the Company to repurchase up to $25 million of its common shares in the open market over the next twelve...

August 17, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that Spectrum has provided an additional extension of the...

August 17, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the launch of an authorized generic of ACTOplus met® (pioglitazone/metformin tablets)15 mg/500 mg, 15 mg/850 mg. ACTOplus met® is marketed by Takeda...

August 17, 2012

BETHESDA, Md.--(BUSINESS WIRE)--More than 20 biotech companies that will present business innovations and growth strategies to an audience of more than 850 investors, scientists at Mid-Atlantic Bio Conference September 27-28, 2012.

August 17, 2012

CLEVELAND--(BUSINESS WIRE)--The 2014 CleanMed Conference & Exposition, presented by Practice Greenhealth and Health Care Without Harm, will be held at Cleveland Medical Mart & Convention Center (CMMCC) in May, 2014.

August 17, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received a commitment from an institutional investor to purchase $3,475,000 of securities in a registered direct offering. BioSante...